Nakamura–Vasconcelos SS, et al. – In this research, authors study the susceptibility to antifungal agents of C. glabrata isolated from vaginal samples and some virulence attributes in order to better comprehend why these species are emerging as the main vulvovaginal candidiasis (VVC) agents. These outcomes allow hypothesizing that C. glabrata is an emergent agent in VVC probably because the treatment with fluconazole selects this species. But once adhered, yeasts remain on biotic or abiotic surfaces causing colonization or VVC symptomatology.